InvestorsHub Logo
icon url

vinovista

08/16/21 9:20 AM

#26629 RE: Canes16 #26628

KISS
Easier and clearer to do just the one. Then one can add the other drugs as an update which is also easier to get approved.
To the best of my knowledge.

:}
icon url

techxen

08/17/21 5:59 PM

#26632 RE: Canes16 #26628

I suspect it is because Ticagrelor (Brilinta) is an antiplatelet agent. Apixaban (Eliquis) and Rivaroxaban (Xarelto) are anticoagulants.

Don't forget that the company has had positive studies also where they demonstrated successful and safe removal of Dabigatran (Pradaxa) and Edoxaban (Savaysa) so I suspect those two agents will be next.